Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.77 USD | +1.70% | +2.31% | +30.88% |
Financials (USD)
Sales 2024 * | 132M | Sales 2025 * | 174M | Capitalization | 1.96B |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -26M | EV / Sales 2024 * | 14.2 x |
Net cash position 2024 * | 92.68M | Net cash position 2025 * | 87M | EV / Sales 2025 * | 10.8 x |
P/E ratio 2024 * |
-53.7
x | P/E ratio 2025 * |
-74.6
x | Employees | 374 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.58% |
Latest transcript on RxSight, Inc.
1 day | +1.70% | ||
1 week | +2.31% | ||
Current month | +2.31% | ||
1 month | +2.31% | ||
3 months | +12.04% | ||
6 months | +147.86% | ||
Current year | +30.88% |
Managers | Title | Age | Since |
---|---|---|---|
Ronald Kurtz
CEO | Chief Executive Officer | 60 | 15-05-31 |
Shelley Thunen
DFI | Director of Finance/CFO | 72 | 15-12-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Palmisano
BRD | Director/Board Member | 79 | 21-08-09 |
Bill Link
BRD | Director/Board Member | 78 | 16-10-31 |
Ronald Kurtz
CEO | Chief Executive Officer | 60 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +6.26% | - | |
0.00% | 147 M€ | +4.88% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 52.77 | +1.70% | 273,467 |
24-04-25 | 51.89 | -1.80% | 364,837 |
24-04-24 | 52.84 | -3.79% | 288,150 |
24-04-23 | 54.92 | +4.93% | 343,269 |
24-04-22 | 52.34 | +1.47% | 270,112 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.88% | 1.96B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- RXST Stock